Pharmaceuticals, Biotechnology and Life Sciences
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque…
SteQeyma™ 45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration…
San Diego, CA, Dec. 17, 2025 (GLOBE NEWSWIRE) — Sapu BioScience today announced the publication of a new peer-reviewed study…
HONG KONG, Dec. 17, 2025 (GLOBE NEWSWIRE) — Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) (“HKPD” or the…
Novel treatment for PSVT developed with Milestone Pharmaceuticals CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–Aptar Group, Inc. (NYSE: ATR), a global leader in…
DUBLIN–(BUSINESS WIRE)–The “Malabsorption Syndrome Market – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market for…
DUBLIN–(BUSINESS WIRE)–The “Constipation Treatment – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market for Constipation…
Minjuvi® (tafasitamab) in combination with lenalidomide and rituximab is the first CD19- and CD20-dual-targeted immunotherapy combination regimen approved for eligible…
SEATTLE & TOKYO–(BUSINESS WIRE)–Talus Bioscience, Inc. (“Talus Bio”), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRISM…
DUBLIN–(BUSINESS WIRE)–The “Short Bowel Syndrome (SBS) – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market…